These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25824212)

  • 1. Population pharmacokinetics of benznidazole in adult patients with Chagas disease.
    Soy D; Aldasoro E; Guerrero L; Posada E; Serret N; Mejía T; Urbina JA; Gascón J
    Antimicrob Agents Chemother; 2015; 59(6):3342-9. PubMed ID: 25824212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole.
    Fernández ML; Marson ME; Ramirez JC; Mastrantonio G; Schijman AG; Altcheh J; Riarte AR; Bournissen FG
    Mem Inst Oswaldo Cruz; 2016 Mar; 111(3):218-21. PubMed ID: 26982179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and Tissue Distribution of Benznidazole after Oral Administration in Mice.
    Perin L; Moreira da Silva R; Fonseca KD; Cardoso JM; Mathias FA; Reis LE; Molina I; Correa-Oliveira R; Vieira PM; Carneiro CM
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetic study of benznidazole in pediatric Chagas disease suggests efficacy despite lower plasma concentrations than in adults.
    Altcheh J; Moscatelli G; Mastrantonio G; Moroni S; Giglio N; Marson ME; Ballering G; Bisio M; Koren G; García-Bournissen F
    PLoS Negl Trop Dis; 2014 May; 8(5):e2907. PubMed ID: 24853169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited infant exposure to benznidazole through breast milk during maternal treatment for Chagas disease.
    García-Bournissen F; Moroni S; Marson ME; Moscatelli G; Mastrantonio G; Bisio M; Cornou L; Ballering G; Altcheh J
    Arch Dis Child; 2015 Jan; 100(1):90-4. PubMed ID: 25210104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial.
    Molina-Morant D; Fernández ML; Bosch-Nicolau P; Sulleiro E; Bangher M; Salvador F; Sanchez-Montalva A; Ribeiro ALP; de Paula AMB; Eloi S; Correa-Oliveira R; Villar JC; Sosa-Estani S; Molina I
    Trials; 2020 Apr; 21(1):328. PubMed ID: 32293523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of Benznidazole in Healthy Volunteers and Implications in Future Clinical Trials.
    Molina I; Salvador F; Sánchez-Montalvá A; Artaza MA; Moreno R; Perin L; Esquisabel A; Pinto L; Pedraz JL
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of benznidazole in neonates, infants and children using a new pediatric formulation.
    Altcheh J; Moscatelli G; Caruso M; Moroni S; Bisio M; Miranda MR; Monla C; Vaina M; Valdez M; Moran L; Ramirez T; Patiño OL; Riarte A; Gonzalez N; Fernandes J; Alves F; Ribeiro I; Garcia-Bournissen F
    PLoS Negl Trop Dis; 2023 May; 17(5):e0010850. PubMed ID: 37256863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Review and Meta-analysis of the Pharmacokinetics of Benznidazole in the Treatment of Chagas Disease.
    Wiens MO; Kanters S; Mills E; Peregrina Lucano AA; Gold S; Ayers D; Ferrero L; Krolewiecki A
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7035-7042. PubMed ID: 27550362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of Benznidazole in Experimental Chronic Chagas Disease Using the Swiss Mouse-Berenice-78 Trypanosoma cruzi Strain Model.
    de Jesus SM; Pinto L; Moreira FL; Nardotto GHB; Cristofoletti R; Perin L; Fonseca KDS; Barbêdo P; Bandeira LC; Vieira PMA; Carneiro CM
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33168611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous liposomal benznidazole as trypanocidal agent: increasing drug delivery to liver is not enough.
    Morilla MJ; Montanari JA; Prieto MJ; Lopez MO; Petray PB; Romero EL
    Int J Pharm; 2004 Jul; 278(2):311-8. PubMed ID: 15196636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dried Blood Spot Technique-Based Liquid Chromatography-Tandem Mass Spectrometry Method as a Simple Alternative for Benznidazole Pharmacokinetic Assessment.
    Galindo Bedor DC; Tavares Cavalcanti Bedor NC; Viturino da Silva JW; Damasceno Sousa G; Pereira de Santana D; Garcia-Bournissen F; Altcheh J; Blum B; Alves F; Ribeiro I
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30275095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benznidazole in Cerebrospinal Fluid: a Case Series of Chagas Disease Meningoencephalitis in HIV-Positive Patients.
    Fernández ML; Marson ME; Mastrantonio GE; Corti MA; Fleitas U; Lloveras SC; Lista N; Priarone MM; Domínguez C; Garcia-Bournissen F
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetic modeling of benznidazole in Brazilian patients with chronic Chagas disease.
    Frade VP; Moreira CHV; Sabino EC; Bedor DCG; Ghilard FR; Oliveira CDL; Sanches C
    Rev Inst Med Trop Sao Paulo; 2022; 64():e4. PubMed ID: 35137898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of escalating doses of caspofungin in a phase II study of patients with invasive aspergillosis.
    Würthwein G; Cornely OA; Trame MN; Vehreschild JJ; Vehreschild MJ; Farowski F; Müller C; Boos J; Hempel G; Hallek M; Groll AH
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1664-71. PubMed ID: 23335740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
    Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial.
    Torrico F; Gascon J; Ortiz L; Alonso-Vega C; Pinazo MJ; Schijman A; Almeida IC; Alves F; Strub-Wourgaft N; Ribeiro I;
    Lancet Infect Dis; 2018 Apr; 18(4):419-430. PubMed ID: 29352704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-Drug Interaction Study of Benznidazole and E1224 in Healthy Male Volunteers.
    Ribeiro I; Blum B; Fernandes J; Santina G; Asada M; Everson M; Schuck E; Feleder E; Evene E; Gualano V
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33558286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benznidazole vs benznidazole in multilamellar liposomes: how different they interact with blood components?
    Morilla MJ; Prieto MJ; Romero EL
    Mem Inst Oswaldo Cruz; 2005 Apr; 100(2):213-9. PubMed ID: 16021311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole-benznidazole based on amorphous solid dispersions.
    Figueirêdo CBM; Nadvorny D; Vieira ACQM; Schver GCRM; Soares Sobrinho JL; Rolim Neto PJ; Lee PI; Soares MFR
    Eur J Pharm Sci; 2018 Jul; 119():208-218. PubMed ID: 29679707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.